TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

Charles M Rudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.